Intracranial meningiomas and neurofibromatosis type 2

Acta Neurochirurgica

Volumn 155, Issue 6, 2013, Pages 997-1001

  Aboukais, Rabih ^a   Zairi, Fahed ^a   Baroncini, Marc ^a   Bonne, Nicolas Xavier ^a   Schapira, Stéphane ^a   Vincent, Christophe ^a   Lejeune, Jean Paul ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Meningioma; NF2; Prognosis; Spinal tumors

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN MENINGIOMA; CANCER GRADING; CHILD; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MENINGIOMA; NEURILEMOMA; NEUROFIBROMATOSIS; NEUROSURGERY; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN TUMOR; SPINAL CORD TUMOR; TUMOR LOCALIZATION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; FOLLOW-UP STUDIES; GENES, NEUROFIBROMATOSIS 2; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENINGIOMA; MIDDLE AGED; MUTATION; NEUROFIBROMATOSIS 2; PROGNOSIS; RETROSPECTIVE STUDIES; SPINAL NEOPLASMS; YOUNG ADULT;

EID: 84878781477     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-013-1692-2     Document Type: Article

References (24)

1. Goutagny S, Kalamarides M (2010) Meningiomas and neurofibromatosis. J Neurooncol 99:341-347
2. Goutagny S, Bah AB, Henin D, Parfait B, Grayeli AB, Sterkers O, Kalamarides M (2012) Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features. Neuro-Oncology 14:1090-1096
3. Omeis I, Hillard VH, Braun A, Benzil DL, Murali R, Harter DH (2006) Meningioangiomatosis associated with neurofibromatosis: report of 2 cases in a single family and review of the literature. Surg Neurol 65:595-603 (Pubitemid 43729609)
4. Stemmer-Rachamimov AO, Horgan MA, Taratuto AL, Munoz DG, Smith TW, Frosch MP, Louis DN (1997) Meningioangiomatosis is associated with neurofibromatosis 2 but not with somatic alterations of the NF2 gene. J Neuropathol Exp Neurol 56:485-489 (Pubitemid 27463090)
5. Begnami MD, Palau M, Rushing EJ, Santi M, Quezado M (2007) Evaluation of NF2 gene deletion in sporadic schwannomas, meningiomas, and ependymomas by chromogenic in situ hybridization. Hum Pathol 38:1345-1350 (Pubitemid 47247477)
6. Begnami MD, Rushing EJ, Santi M, Quezado M (2007) Evaluation of NF2 gene deletion in pediatric meningiomas using chromogenic in situ hybridization. Int J Surg Pathol 15:110-115 (Pubitemid 46548107)
7. Parry DM, MacCollin MM, Kaiser-Kupfer MI, Pulaski K, Nicholson HS, Bolesta M, Eldridge R, Gusella JF (1996) Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. Am J Hum Genet 59:529-539 (Pubitemid 26269030)
8. Ruttledge MH, Andermann AA, Phelan CM, Claudio JO, Han FY, Chretien N, Rangaratnam S, MacCollin M, Short P, Parry D, Michels V, Riccardi VM, Weksberg R, Kitamura K, Bradburn JM, Hall BD, Propping P, Rouleau GA (1996) Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet 59:331-342 (Pubitemid 26266348)
9. Selvanathan SK, Shenton A, Ferner R, Wallace AJ, Huson SM, Ramsden RT, Evans DG (2010) Further genotype-phenotype correlations in neurofibromatosis 2. Clin Genet 77:163-170
10. Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R (1992) A clinical study of type 2 neurofibromatosis. Q J Med 84:603-618 (Pubitemid 23007763)
11. Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, Strachan T, Harris R (1992) A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling. J Med Genet 29:847-852 (Pubitemid 23035206)
12. Evans DG, Huson SM, Donnai D, Neary W, Blair V, Teare D, Newton V, Strachan T, Ramsden R, Harris R (1992) A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 29:841-846 (Pubitemid 23035205)
13. Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N (1994) Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 52:450-461 (Pubitemid 24298996)
14. Lamszus K (2004) Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol 63:275-286 (Pubitemid 38429025)
15. Antinheimo J, Haapasalo H, Haltia M, Tatagiba M, Thomas S, Brandis A, Sainio M, Carpen O, Samii M, Jaaskelainen J (1997) Proliferation potential and histological features in neurofibromatosis 2-associated and sporadic meningiomas. J Neurosurg 87:610-614 (Pubitemid 27430405)
16. De Tommasi A, Occhiogrosso M, De Tommasi C, Cimmino A, Sanguedolce F, Vailati G (2005) Radiation-induced intracranial meningiomas: review of six operated cases. Neurosurg Rev 28:104-114 (Pubitemid 40543808)
17. Bauchet L, Rigau V, Mathieu-Daude H, Figarella-Branger D, Hugues D, Palusseau L, Bauchet F, Fabbro M, Campello C, Capelle L, Durand A, Tretarre B, Frappaz D, Henin D, Menei P, Honnorat J, Segnarbieux F (2007) French brain tumor data bank: methodology and first results on 10,000 cases. J Neurooncol 84:189-199 (Pubitemid 47202129)
18. Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamarides M, Menei P, Deruty R, Moreau JJ, Fevre-Montange M, Guyotat J (2009) WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 95:367-375
19. Kim YJ, Ketter R, Henn W, Zang KD, Steudel WI, Feiden W (2006) Histopathologic indicators of recurrence in meningiomas: correlation with clinical and genetic parameters. Virchows Archiv: Int J Pathol 449:529-538 (Pubitemid 44722321)
20. Christiaans I, Kenter SB, Brink HC, van Os TA, Baas F, van den Munckhof P, Kidd AM, Hulsebos TJ (2011) Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas. J Med Genet 48:93-97
21. van den Munckhof P, Christiaans I, Kenter SB, Baas F, Hulsebos TJ (2012) Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri. Neurogenetics 13:1-7
22. Bosch MM, Wichmann WW, Boltshauser E, Landau K (2006) Optic nerve sheath meningiomas in patients with neurofibromatosis type 2. Arch Ophthalmol 124:379-385
23. da Cruz MJ, Hardy DG, Moffat DA (2000) Clinical presentation of a group of NF2 patients to a tertiary referral skull base unit. Br J Neurosurg 14:101-104 (Pubitemid 30258896)
24. Baser ME, Friedman JM, Aeschliman D, Joe H, Wallace AJ, Ramsden RT, Evans DG (2002) Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet 71:715-723 (Pubitemid 135750506)